| 711 |
decreased |
abnormal circulating hormone level
(MP:0005418)
|
3,3',5'-triiodothyronine
(CHEBI:28774)
|
None
|
| 712 |
decreased |
abnormal circulating hormone level
(MP:0005418)
|
3,3',5-triiodo-L-thyronine
(CHEBI:18258)
|
None
|
| 713 |
decreased |
abnormal circulating hormone level
(MP:0005418)
|
|
None
|
| 716 |
decreased |
hypoxia
(MP:0005039)
|
hypoxia-inducible factor 1-alpha
(PR:000008555)
|
1394: Induction, persistent proliferation/sustained proliferation
|
| 717 |
decreased |
hypoxia
(MP:0005039)
|
von Hippel-Lindau disease tumor suppressor
(PR:000017294)
|
1394: Induction, persistent proliferation/sustained proliferation
|
| 718 |
decreased |
hypoxia-inducible factor-1alpha signaling pathway
(GO:0097411)
|
von Hippel-Lindau disease tumor suppressor
(PR:000017294)
|
None
|
| 720 |
decreased |
phagocytosis
(GO:0006909)
|
macrophage
(CL:0000235)
|
1668: Frustrated phagocytosis
|
| 726 |
decreased |
androgen biosynthetic process
(GO:0006702)
|
|
None
|
| 727 |
decreased |
androgen biosynthetic process
(GO:0006702)
|
11-Keto-testosterone
(CHEBI:34133)
|
1756: Decreased, plasma 11-ketotestosterone level
|
| 729 |
decreased |
activin receptor signaling pathway
(GO:0032924)
|
activin complex
(GO:0048180)
|
None
|
| 730 |
decreased |
activin receptor signaling pathway
(GO:0032924)
|
activin receptor complex
(GO:0048179)
|
None
|
| 731 |
decreased |
fin regeneration
(GO:0031101)
|
blastemal cell
(CL:0000354)
|
1761: Inhibition, Fin regeneration
|
| 734 |
decreased |
cholesterol transport
(GO:0030301)
|
cholesterol
(CHEBI:16113)
|
807: Decreased, cholesterol
|
| 735 |
decreased |
cholesterol transport
(GO:0030301)
|
cholesteryl ester
(CHEBI:17002)
|
807: Decreased, cholesterol
|
| 739 |
decreased |
population growth rate
(PCO:0000008)
|
population of organisms
(PCO:0000001)
|
360: Decrease, Population growth rate
|
| 743 |
decreased |
regulation of binding
(GO:0051098)
|
|
None
|
| 744 |
decreased |
protein dephosphorylation
(GO:0006470)
|
|
None
|
| 745 |
decreased |
negative regulation of DNA binding
(GO:0043392)
|
protein-DNA complex
(GO:0032993)
|
1717: Suppression of STAT5 binding to cytokine gene promoters
|
| 746 |
decreased |
T cell activation involved in immune response
(GO:0002286)
|
|
1719: Impairment of T-cell dependent antibody response
|
| 747 |
decreased |
regulation of binding
(GO:0051098)
|
tyrosine-protein kinase JAK3
(PR:000009198)
|
1715: Inhibition of JAK3
|
| 748 |
decreased |
protein dephosphorylation
(GO:0006470)
|
signal transducer and transcription activator STAT
(PR:000001933)
|
1716: Blockade of STAT5 phosphorylation
|
| 749 |
decreased |
cuticle development
(GO:0042335)
|
cuticle
(UBERON:0001002)
|
1523: Decrease, Cuticular chitin content
|
| 750 |
decreased |
ecdysis, chitin-based cuticle
(GO:0018990)
|
|
1524: Increase, Premature molting
|
| 751 |
decreased |
chitin synthase activity
(GO:0004100)
|
|
1522: Inhibition, Chitin synthase 1
|
| 752 |
decreased |
cell proliferation
(GO:0008283)
|
cell
(GO:0005623)
|
1821: Decrease, Cell proliferation
|